Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Pat Anal ; 7(4): 155-167, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29882724

ABSTRACT

Celastrol is a highly investigated anticancer moiety. It is a pentacyclic triterpenoid, isolated several decades ago with promising role in chemoprevention. Celastrol has been found to target multiple proinflammatory, angiogenic and metastatic proteins. Inhibition of these targets results in significant reduction of cancer growth, survival and metastasis. This review summarizes the varied molecular targets of celastrol along with insight into the various recently published clinical, preclinical and industrial patents (2011-2017).


Subject(s)
Antineoplastic Agents , Patents as Topic , Triterpenes , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Humans , Neoplasms/drug therapy , Pentacyclic Triterpenes , Triterpenes/chemistry , Triterpenes/pharmacology , Triterpenes/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...